Search
Search Results
-
Immuntherapie beim metastasierten Mammakarzinom
Immune checkpoint inhibitors are playing an increasing role in the treatment of solid tumors. Currently, they are only approved for treatment of...
-
-
-
Nachsorge beim Mammakarzinom – endlich Bewegung?
The follow-up care after curative primary treatment is a central component for patients with breast cancer and has remained unchanged in routine...
-
-
Antikörper-Wirkstoff-Konjugate beim metastasierten Mammakarzinom
BackgroundMolecular factors play a crucial role in the development of targeted therapies for metastatic breast cancer.
ObjectiveThis study aimed to...
-
-
-
-
Triple-negatives Mammakarzinom
Triple-negative breast cancer (TNBC) accounts for about 10% of all breast cancer cases and is defined by the lack of expression of estrogen and...
-
-
Präzisionsonkologie, molekulares Tumorboard und translationale Programme beim metastasierten Mammakarzinom
BackgroundDrug therapy of metastatic breast cancer is becoming increasingly individualized. Precision oncology opens up new perspectives for...